AI tools like OpenProtein are reshaping protein engineering—flexible workflows for any class, from therapeutics to biotech. Boehringer Ingelheim shows how machine learning speeds modeling and design. Explore the future of protein design! #AIProteinDesign #ProteinEngineering #MachineLearning
🔗
🔗
April 17, 2026 at 5:16 PM
AI tools like OpenProtein are reshaping protein engineering—flexible workflows for any class, from therapeutics to biotech. Boehringer Ingelheim shows how machine learning speeds modeling and design. Explore the future of protein design! #AIProteinDesign #ProteinEngineering #MachineLearning
🔗
🔗
Sungkyunkwan University researchers engineered AI-derived Deam-P32 into OpenABE1.1/1.2 by grafting a missing C-terminal domain and 3 key mutations, matching ABE8e's 41.7% efficiency while slashing ATC bystander edits up to 12-fold. 🧬🤖 #BaseEditing #CRISPR #OpenABE #NAR2026 #AIProteinDesign #Biotech
July 30, 2026 at 5:44 AM
Sungkyunkwan University researchers engineered AI-derived Deam-P32 into OpenABE1.1/1.2 by grafting a missing C-terminal domain and 3 key mutations, matching ABE8e's 41.7% efficiency while slashing ATC bystander edits up to 12-fold. 🧬🤖 #BaseEditing #CRISPR #OpenABE #NAR2026 #AIProteinDesign #Biotech
Exploring fibrous proteins & AI-driven design for advanced biomedical & industrial applications. #ProteinMaterials #AIProteinDesign #Bioengineering
Details: doi.org/10.1016/j.bidere.2025.100004
Details: doi.org/10.1016/j.bidere.2025.100004
June 20, 2025 at 2:32 PM
Exploring fibrous proteins & AI-driven design for advanced biomedical & industrial applications. #ProteinMaterials #AIProteinDesign #Bioengineering
Details: doi.org/10.1016/j.bidere.2025.100004
Details: doi.org/10.1016/j.bidere.2025.100004
UPenn researchers developed a pooled mammalian screening framework for AI-designed ubiquibodies, using FACS and NGS to identify functional peptide-guided degraders targeting beta-catenin, GFAP, EWS::FLI1, and endogenous GATA2. 🧬🤖 #ProteinDegradation #TPD#bioRxiv2026 #AIProteinDesign #Ubiquibody
August 28, 2026 at 8:15 AM
UPenn researchers developed a pooled mammalian screening framework for AI-designed ubiquibodies, using FACS and NGS to identify functional peptide-guided degraders targeting beta-catenin, GFAP, EWS::FLI1, and endogenous GATA2. 🧬🤖 #ProteinDegradation #TPD#bioRxiv2026 #AIProteinDesign #Ubiquibody
Another day of #yeastdisplay! Today, students learned #antigenbiotinylation, #FACS, and #AIproteindesign. Thanks to today’s sponsor, Alloy Therapeutics, for sharing more on #antibodydiscovery via mammalian cell-based directed evolution!
News on courses and events: buff.ly/ZKR3alr
News on courses and events: buff.ly/ZKR3alr
June 3, 2026 at 10:57 PM
Another day of #yeastdisplay! Today, students learned #antigenbiotinylation, #FACS, and #AIproteindesign. Thanks to today’s sponsor, Alloy Therapeutics, for sharing more on #antibodydiscovery via mammalian cell-based directed evolution!
News on courses and events: buff.ly/ZKR3alr
News on courses and events: buff.ly/ZKR3alr